Introduction
Glucose intolerance and overt diabetes are well recognized in patients with cirrhosis of the liver. Since the advent of radioimmunoassay, numerous studies have shown high circulating insulin levels and this, together with unresponsiveness to exogenous insulin, have led to the concept of insulin resistance in this condition (for review see Alberti & Johnston, 1979) . At first porto-systemic shunting of insulin-rich blood was thought to be the cause of the peripheral hyperinsulinaemia, but studies in patients with porto-systemic shunting but no evidence of liver cell damage showed very little derangement of insulin metabolism or glucose homeostasis (Johnston, Alberti, Wright, SmithLaing, Stewart, Sherlock, Faber & Binder, 1978) . In addition to hepatocyte damage factors such as impaired nutrition, steroids, diuretics and hypokalaemia affect glucose tolerance and may mask the effect of cirrhosis alone. The present study was designed to examine in more detail peripheral glucose metabolism during glucose loading in cirrhotic patients. Oral glucose tolerance tests were performed on patients with stable compensated cryptogenic cirrhosis and forearm glucose uptake was assessed. At the same time other factors which may influence extrahepatic glucose metabolism, such as nonesterified fatty acids, growth hormone and potassium, were determined.
Methods
Six patients (five males and one female; mean age 5 5 5 years) with compensated cryptogenic cirrhosis were studied. Three were outpatients 0143-5221/80/090191-08$01.50/1 0 1980 The Biochemical Society and the Medical Research Society and three ambulatory inpatients at the time of study. All had biopsy-proven hepatic cirrhosis. Histologically inflammatory changes were minimal and the aetiology of cirrhosis was obscure. One patient's blood, however, was positive for hepatitis B antigen. All patients had portal hypertension with oesophageal varices confirmed endoscopically or on barium swallow examination. A control group of 12 normal volunteer subjects (ten males and two females; mean age 46 & 5 years) was also studied. Patients and controls were asked to consume at least 220 g of carbohydrate daily for 3 days before the test. None of the patients or controls had any family history of diabetes mellitus nor had they been taking drugs for at least 2 weeks before the study. There were no statistically significant differences between controls and cirrhotic patients with respect to age, height, weight, percentage ideal body weight (96 k 2.7 compared with 93 k 2.4%), forearm volume (0.99 k 0.04 compared with 0.9 1 f 0.07 litre) or forearm circumference (26.3 f 0.4 compared with 25.2 f 1.2 cm).
Subjects were studied at 09.30 hours, having fasted from 22.00 hours the previous evening. The nature of the experiment had been explained to them previously and all had given full consent. They remained semi-recumbent throughout the test and basal samples were not taken until after at least 30 min of rest. After basal blood sampling 100 g of glucose in water (with a dash of pure lemon juice to increase palatability) was given and samples were collected at 15 min intervals for 3 h.
Arterialized-venous and mixed venous blood samples were taken simultaneously from indwelling cannulae. Concentrations of hormones and metabolites refer to arterialized-venous blood, which was used throughout the experiment as a substitute for arterial blood as described and validated by Jackson, Advani, Perry, Rogers, Peters, Day & Pilkington (1973) . The mixed venous cannula (Butterfly 19G Abbot Laboratories) was inserted into the antecubital fossa of one arm, usually the right. Care was taken that a vein was chosen which appeared to drain predominantly the deep compartment of the forearm, veins draining superficial structures being avoided. The arterialized-venous cannula (Butterfly 23) was inserted into a distally placed vein in the dorsum of the opposite hand with its tip pointing towards the fingers. The hand was placed between two heating pads warmed to 40-50"C throughout the experiment (including sampling periods). Patency of both cannulae was maintained by flushing with sodium citrate solution after blood sampling. Blood flow was measured by venous occlusion plethysmography with a mercury-in-rubber strain gauge. Venous occlusion was produced in the arm bearing the mixed venous cannula by inflation of a 3 inch sphygmomanometer cuff to just below diastolic blood pressure. This cuff (collecting cuff) was placed on the upper arm and a 2 inch cuff (arresting cuff) was placed around the wrist of the same arm and inflated to 220 mmHg, to arrest circulation in the hand. The arresting and collecting cuffs were inflated simultaneously by an electrical pump. The arresting cuff was continuously inflated during blood-flow measurements and blood sampling. The collecting cuff was inflated for 8-10 s every 15 s for a period of 3 min and during occlusion a plethysmographic record was obtained on a Sanborn four-channel recorder (Hewlett Packard Ltd, Altrincham, Cheshire, U.K.). The method and its validation have been previously described (Jackson et al., 1973) .
Blood was collected in fluoride/oxalate tubes for triplicate plasma glucose determinations by the ferricyanide autoanalyser technique. For lactate and pyruvate determinations (Hohorst, Kreutz & Bucher, 1959) 3 ml of whole blood was added to 3 ml of ice-cold perchloric acid (0.63 mol/l) and the supernatant was neutralized with potassium hydroxide (1.78 mol/l) before assay. Serum insulin and growth hormone were determined by micromodifications of the radioimmunoassays of Soeldner & Slone (1965) and Boden & Soeldner (1 967) respectively. Blood glycerol was measured by the method of Kreutz (1 962) and plasma non-esterified fatty acids were measured colorimetrically as described by Itaya & Ui (1965) .
Statistical methods
The values shown are means k SEM. For glucose, insulin, forearm glucose uptake and growth hormone levels the distribution-independent Mann-Whitney U-test (Seigel, 1956 ) was used to compare values between groups at each time point. The sign test was used to assess the significance of arteriovenous glucose differences and the Student's f-test in all other cases.
Forearm glucose uptake was calculated by multiplying plasma flow by arterialized-venousmixed venous differences. Individual blood flows were corrected for packed cell volume at each time point and mean plasma flows are shown. There were times (11% of readings in normal subjects, 5% in cirrhotic patients) when individual values of blood flow were greater than 60 ml min-' 1-I of forearm but in only one instance (83 ml) was the blood flow greater than 80 ml min-' 1-' of forearm. With increasing forearm blood flow the proportion supplying voluntary muscle decreases progressively (Cooper, Edholm & Mottram, 1955) but no correction has been applied to our results to take account of this factor.
Areas under curves were calculated from incremental values. They were calculated for 15 rnin intervals (30 rnin intervals for lactate) and summed to give total areas.
Results
All the cirrhotic patients had some abnormality of liver-function tests. Quick's one-stage prothrombin time was prolonged in all subjects by a mean of 4 s (range 1-6 s). Mean serum bilirubin was 45 pmolll (normal 3-20 ,umol/l; range 32-78 pmolll). Serum aspartate aminotransferase was normal in two subjects but the mean value was 103 i d 1 (normal 10-15 i.u./l; range 26-200 i.u./l). Mean serum albumin level was 34 g/l (normal 35-50 g/l; range 29-41 g/l). Serum alkaline phosphatase was normal in one subject but the mean value was 171 i.u./l (normal 30-85 i d l ; range 58-247 i.u./l). Blood urea was normal (<7 mmol/l) except in one patient with a value of 10.2 mmol/l. In control subjects and cirrhotic patients serum potassium was normal (3-5-4-8 mmol/l). Packed cell volume was significantly lower in cirrhotic patients (36.1 2 1.6%) compared with control subjects (41.0 f 0.7%).
There was a tendency for blood flow to increase slightly in the later stages of the experiment but the rise was not statistically significant. Mean blood flow in cirrhotic patients was 40 ml min-' 1-' of forearm (range 30-52) compared with 44 ml min-l 1-' of forearm (range 38-49) in control subjects. Mean plasma flow in cirrhotic patients was 26 ml min-' 1-' of forearm (range 20-33) compared with 26 ml mix-' 1-' of forearm (range 22-30) in control subjects. The differences were not statistically significant when analysed for each 15 rnin period.
Fasting plasma glucose, serum insulin, serum growth hormone, blood pyruvate and forearm glucose uptake were similar in the two groups but blood lactate, glycerol and free fatty acids were significantly greater in cirrhotic patients than controls ( Table 1) .
Four of the six patients with cirrhosis had glucose intolerance (maximum mixed venous glucose greater than 10 mmol/l). Incremental glucose levels are shown in Fig. 1 . They were similar during the first 45 rnin of the test but thereafter were significantly elevated in cirrhotic patients except at 135 and 150 min. Hourly incremental glucose areas were significantly increased in cirrhotic patients throughout the test ( Table 2) .
Serum insulin concentrations were similar for the first 45 rnin of the test and thereafter were significantly elevated in the cirrhotic group (Fig.  2) . The incremental insulin area was significantly greater in cirrhotic patients compared with control subjects in the hours 2 and 3 of the test, although the overall 3 h areas were similar ( Table  2) . When results were expressed as insulin/ glucose ratios, AinsulidAglucose (where A = total incremental area under the curve) values for cirrhotic patients were 12.4 21.7 and for controls 17.2 2 18.6. This difference was not significant, nor were similar ratios which were calculated for each hour of the test. Serum growth hormone concentrations are compared in Table 3 . There was a failure of suppression by glucose loading in the cirrhotic group with a rise above basal levels in hour 3 of the test. The levels were significantly increased compared with controls from 30 rnin onwards.
The lactate response to glucose was of equal magnitude in patients with cirrhosis (0.66 ? 0.12 and control subjects (@---a). Values are means f SEM. Levels of significance: * P < 0.05; ** P < 0.025; t P < 0.005. mmol/l) and controls (0.62 k 0.75 mmol/l) but in the former the peak occurred later and was more sustained (Fig. 3) . The total area under the curve was similar in the two groups but in the first hour the lactate response in controls was significantly greater than in cirrhotic patients TABLE 2. Hourly and total incremental areas for plasma glucose, serum insulin, blood lactate and forearm glucose uptake and ratios of forearm glucose uptake to insulin areas during the course of the glucose-tolerance test in patients with cirrhosis and control subjects Incremental areas were the areas under the concentration-time curves for individual patients. Total areas were calculated for 3 h. Significance of differences, calculated by using the Mann-Whitney U-test, except for lactate (t-test): *P < 0.05; **P < 0.01). while in the last hour there was a highly significant increase in the lactate area in cirrhotic patients ( Table 2) . Forearm arterialized-venous -mixed venous differences for insulin and growth hormone revealed no significant trends. Arterialiied-venous -mixed venous differences for glucose and for lactate are shown in Table 4 . Mean arterializedvenous -mixed venous differences for glucose in controls were always positive and were significantly different from zero at all times except basally and at 180 min. In cirrhotic patients arterialized-venous -mixed venous differences were always positive and were significantly less than in controls at 90, 135 and 165 min. Although always negative, arterializedvenous -mixed venous lactate differences in cirrhotic patients were not significantly different from zero. They were significantly different from controls, however, in the fasting state and at 60, Fig. 4 ; Table 5 ). The ratio of forearm glucose-uptake area to insulin area was significantly decreased in cirrhotic patients in hours 2 and 3 ( Table 2 ).
Discussion
Many workers have shown the co-existence of hyperinsulinism and glucose intolerance in cirrhosis. By studying C-peptide concentrations, Johnston, Alberti, Faber, Binder & Wright (1977) have shown that the hyperinsulinism of cirrhosis is due primarily to impaired insulin degradation rather than increased pancreatic secretion. The present study was designed to assess the effect of high insulin concentrations in cirrhotic patients on glucose uptake in the periphery. The results suggest that despite higher than normal peripheral glucose and insulin levels in cirrhotic patients there was no significant alteration in forearm glucose uptake. Recent evidence suggests that low concentrations of insulin are effective in the fasting state in maintaining normoglycaemia by reducing hepatic glucose output. Higher concentrations of insulin have a dual effect of further decreasing hepatic glucose output and increasing peripheral glucose uptake (Issekutz, Issekutz, Elahi & Borkov, 1974; Brown, Tompkins, Juul & Sonksen, 1978) . The studies of Christensen & Orskov (1968) suggest that there is a plateau for insulin concentrations above which no further metabolic effect i s seen and their experiments suggested a plateau occurs at about 200 punits/ml. This is higher than values in our patients during hours 2 and 3 of the test (80-90 p-units/ml) when levels were significantly greater than in controls. One might therefore have expected the higher insulin levels in the cirrhotic paticnts in the presence of high substrate concentrations to increase forearm glucose uptake and so reduce plasma levels. The forearm was unable to increase glucose uptake at these times, the ratio of forearm glucose uptake area to insulin area in cirrhotic patients in hours 2 and 3 of the test being significantly decreased. This indicates insensitivity of peripheral tissues to insulin.
In the past it has been suggested that insensitivity of peripheral tissues to high insulin levels is due to either an increase in non-esterified fatty acids or an elevation of growth hormone concentrations (Mortiaux & Dawson, 196 1; Conn & Daughaday, 1970) . The patients with cirrhosis had significantly higher fasting nonesterified fatty acids than control subjects and this may have contributed to the impairment of insulin action but past efforts have failed to correlate non-esterified fatty acid levels with glucose intolerance (Alberti & Johnson, 1979) . There were significant differences in growth hormone levels in the cirrhotic group after glucose loading with a significant rise during the test. Growth hormone is known to reduce forearm glucose uptake (Zierler & Rabinowitz, 1963; Leatherdale, B. A., Record, C. O., Chase, R. A., Rogers, J., Jackson, R. A., Alberti, K. G. M. M. & Davies, P., unpublished work) but the levels in our patients were within the normal range and the changes occurred simultaneously with or later than the glucose changes. The small changes in growth hormone concentration observed are thus unlikely to account for the insensitivity of the forearm to the high insulin concentrations found in patients with cirrhosis. Insensitivity of the forearm to insulin cannot be the principal cause of glucose intolerance in cirrhotic patients, however, since forearm glucose uptake in the two groups was similar. The primary cause appears to be a failure of retention of glucose in the liver. In the present study, it was possible by using the incremental forearm glucose-uptake areas to calculate the approximate amount of glucose taken up by the peripheral tissues and thus estimate hepatic glucose uptake (Table 5) . These calculations make a number of assumptions about body composition and these have been listed in Table  5 . It can be seen that about half of the glucose load was taken up in peripheral tissues in control subjects but that in patients with cirrhosis there was a 22% decrease in hepatic glucose uptake. This decrease was balanced by the glucose remaining in the glucose space at the end of the test and that lost in the urine (Table 5) .
Glucose taken up by the liver can be incorporated into glycogen or converted into lactate by hepatic glycolysis. In control subjects in the early part of the test arterialized-venous lactate differences were positive, indicating lactate consumption in the forearm at a time when blood lactate concentrations were rising. This suggests that the liver, either by diminishing lactate uptake or actually producing lactate, was the major source of the increased lactate concentration during the first hour after glucose loading as previously suggested by Jackson et al. (1973) .
Although in cirrhotic patients arterialized-venous -mixed venous lactate differences were negative throughout the test, these values were never significantly different from zero and it seems likely that in this group the liver was also the major source of lactate after glucose. In cirrhotic patients, however, the lactate response to glucose was delayed, suggesting impaired hepatic glycolysis. The sustained elevation in blood lactate may have been due to continuing hepatic glycolysis in the presence of high blood glucose concentration or decreased lactate uptake by the liver in the latter part of the test. Thus in cirrhotic patients the lactate responses suggest that impaired hepatic glucose retention is due principally to impaired glycogen synthesis, together with some delay in hepatic glycoly sis.
The association of higher than normal insulin levels with impairment of glucose tolerance constitutes, by definition, insulin resistance but does not indicate the site of the defect. The major sites where insulin influences glucose disposal are muscle and liver and either of these could be the site of defective insulin action. The liver is certainly important in normal man in the disposal of glucose loads. Felig & Wahren (1975) have shown that only 40 g of a 100 g oral glucose load escapes from the splanchnic bed. At the same time hepatic glucose production is inhibited, resulting in a net release of only 15% of the glucose into the periphery. All these values were based on splanchnic balance data. In the present study about 47% of the glucose load could be accounted for by hepatic glucose conservation, a figure slightly lower than that calculated by Jackson et al. (1973) using a similar technique.
The decreased glucose conservation in the liver may have been due to a smaller liver parenchymal cell mass in cirrhotic patients.
Recently there has been great interest in insulin receptor status when carbohydrate homeostatis is disturbed (Flier, Kahn & Roth, 1979) , receptors having been demonstrated on monocytes, hepatocytes, fat and muscle cells. High serum insulin levels in obesity have been shown to be associated with a reduction in both the number and the affinity of receptor sites and weight reduction has led to a fall in insulin levels and a correction of the defect in receptor status (Olfesky, 1976) . Soll, Kahn, Neville & Roth (1975) have demonstrated in obese mice that high insulin concentrations lead to a reduction in receptor sites in liver cell membranes. Furthermore, Tompkins, Sonksen & Jones (1979, using modified insulin, have suggested that there are at least two distinct insulin receptors, one on the hepatocyte and one on peripheral tissues. Recent work has shown diminished numbers of hepatic insulin receptors in experimental galactosamine hepatitis due presumably to hepatocyte damage (Bachmann, Haslbeck, Bottger, Hepp & Mehnert, 1979) . A disturbance in receptor status either in the periphery due to hyperinsulinism or in the liver due to hepatic damage could account for the glucose intolerance and insulin resistance of cirrhosis and clearly this aspect requires further study.
In conclusion, it is suggested that the glucose intolerance of cirrhosis is caused by two factors:
